Top Life Science Categories
Antibodies and Immunology
Cannabis Analysis and Testing
Drug Discovery, Manufacturing and Development
Food and Agricultural Sciences
Lab Automation and Bioinformatics
Proteomics, Metabolomics and Lipidomics
×Top Life Science Categories
Presence of microbes in the lung can modulate lung cancer pathogenesis
Reviewed by Emily Henderson, B.Sc.Nov 12 2020
Bottom Line: Enrichment of the lungs with oral commensal microbes was associated with advanced-stage disease, worse prognosis, and tumor progression in patients with lung cancer.
Image Credit: create jobs 51/Shutterstock.com
Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research
Author: Leopoldo Segal, MD, director of the Lung Microbiome Program, associate professor of medicine at the New York University Grossman School of Medicine, and member of NYU Langone's Perlmutter Cancer Center
Background: "The lungs were long thought to be sterile, but we now know that oral commensals--microbes normally found in the mouth--frequently enter the lungs due to unconscious aspirations," said Segal. While many studies have demonstrated the impact of the gut microbiome on cancer, the impact of the lung cancer microbiome remains unclear.
Prior research from Segal and colleagues showed that the presence of microbes in the lung can activate the immune response, leading to the recruitment of immune cells and inflammatory proteins such as the cytokine IL-17, which has been shown to modulate lung cancer pathogenesis.
Given the known impact of IL-17 and inflammation on lung cancer, we were interested in determining if the enrichment of oral commensals in the lungs could drive an IL-17-type inflammation and influence lung cancer progression and prognosis."
Leopoldo Segal, MD, Director of the Lung Microbiome Program and Associate Professor of Medicine, New York University Grossman School of Medicine
How the Study Was Conducted and Results: In this study, Segal and colleagues analyzed the lung microbiomes of 83 untreated adult patients with lung cancer using samples obtained from diagnostic clinical bronchoscopies. Samples were analyzed to identify microbial composition and to determine which genes were expressed in lung tissue.
The researchers found that patients who had advanced-stage lung cancer (stages 3b-4) had greater enrichment of oral commensals in the lung than those who had the early-stage disease (stages 1-3a). Furthermore, the enrichment of oral commensals in the lung was associated with decreased survival, even after adjusting for the tumor stage.
Olfactory receptor gene may drive breast cancer metastasis to the brain
Study says plant microbiome influences health, survival, and fitness
PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies
Poor prognosis was associated with the enrichment of Veillonella, Prevotella, and Streptococcus bacteria in the lung microbiome, and tumor progression was associated with the enrichment of Veillonella, Prevotella, Streptococcus, and Rothia bacteria.
In patients with early-stage disease, enrichment of Veillonella, Prevotella, and Streptococcus was associated with activation of the p53, PI3K/PTEN, ERK, and IL-6/IL-8 signaling pathways.
A Veillonella strain, found to be enriched in patients with advanced-stage lung cancer, was associated with the expression of IL-17, cell adhesion molecules, cytokines, and growth factors, as well as with the activation of the TNF, PI3K-AKT, and JAK-STAT signaling pathways.
Segal and colleagues also examined the effects of the lung microbiome in a mouse model of lung cancer. They seeded Veillonella parvula in the lungs of mice with lung cancer to model the enrichment of oral commensals.
This led to decreased survival, weight loss, and increased tumor burden and was associated with increased expression of IL-17 and other inflammatory proteins, increased recruitment of immune-suppressing cells, and increased activation of inflammatory pathways.
To understand the role of IL-17 in lung cancer pathogenesis, Segal and colleagues treated Veillonella parvula-enriched mice with an antibody targeted to IL-17, which resulted in a significant decrease in tumor burden compared to mice treated with control.
Author's Comments: "Given the results of our study, it is possible that changes to the lung microbiome could be used as a biomarker to predict prognosis or to stratify patients for treatment," said Segal. "Another exciting possibility is to target the microbiome itself or the host response to microbes as a form of cancer therapy. Our results using an antibody against IL-17 suggest that this could be an effective strategy."
Study Limitations: A limitation of the study was that the sample size prevented additional stratification of patients into subgroups based on the treatments they received. Additionally, since the lung microbiome was only sampled prior to treatment, changes resulting from treatment could not be assessed.
Posted in: Cell Biology | Microbiology | Life Sciences News
Tags: Antibody, Bacteria, Biomarker, Cancer, Cell, Cell Adhesion, Cytokine, Cytokines, Genes, Health Care, Immune Response, Inflammation, Laboratory, Lung Cancer, Lungs, Medical Research, Medicine, Microbiome, Research, Tumor, Weight Loss
Researchers develop new CAR T cells that act as a "micropharmacy"
Research provides novel insights on cancer immunotherapy
Moffitt researchers unravel the role of B cells in endometrial cancer
CSHL researchers spotlight the role of a previously little-known protein in leukemia
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
Targeting MAPK4 in triple-negative breast cancer may lead to improved treatments
Researchers discover a crucial and exploitable vulnerability in diffuse large B cell lymphomas
Simple, marine-dwelling creature shines light on cancer resistance
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Errors in Chemical Analysis
How can Snake Venom Help Aid Drug Discovery?
Genetics of Albinism
Culture Processes for Monoclonal Antibody Production
What Role does Analytical Chemistry Play in Medicine?
Using E.Coli to bring 3D Printing to Life
Dr. Avinash Manjula-Basavanna
In this interview, we speak to Dr. Avinash Manjula Basavanna about his latest research that incorporated E. Coli to bring 3D printing materials to life.
Fluidlab; Combining Cell Counting and Spectrometry to Improve Fluid Analysis
David Heinz
In this interview, we speak to David Heinz from anvajo about their fluidlab technology that combines cell counting and spectrometry to improve fluid analysis.
Cell Counting Without Slides to Reduce Waste and Cost
Daniel Schieffer
Until recently, cells were typically counted on a reusable quartz hemocytometer. With the advent of automated cell counters 12-15 years ago, disposable slides became widespread.
Seed Storing- Protecting the Future of Food
Cultured Meat During the Climate Crisis
The Future of Seaweed Farming
The Use of Marine Invertebrates in Drug Discovery
How Can Proteins Help Organisms to Tell the Time?
Latest Life Science News
Understanding mosquitoes' mating game could help curb the spread of malaria
Predators may buffer the negative impacts of climate change by mitigating against biodiversity loss
Exposure to phthalates may alter a hormone needed to sustain a healthy pregnancy
Cloud-based platform enables easy access to global genomics databases
Researchers conduct genome sequencing studies in children with in-born immunity disorders
AZoLifeSciences.com - An AZoNetwork Site
You might also like... ×
Study shows how skin cells act as a firewall against cancer